scispace - formally typeset
W

Werner Hacke

Researcher at Heidelberg University

Publications -  688
Citations -  93115

Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.

Papers
More filters
Journal ArticleDOI

Acute Cerebrovascular Disease in the Young The Stroke in Young Fabry Patients Study

Arndt Rolfs, +313 more
- 01 Feb 2013 - 
TL;DR: Silent infarcts, white matter intensities, and classical risk factors were highly prevalent, emphasizing the need for new early preventive strategies.
Journal Article

Local Intraarterial Thrombolysis in Vertebrobasilar Thromboembolic Disease

TL;DR: A new therapeutic approach involves selective perfusion of streptokinase through the vertebrobasilar artery via a coaxial catheter system, which demonstrated successful vascular recanalization with clinical improvement.
Journal ArticleDOI

Role of CT Angiography in Patient Selection for Thrombolytic Therapy in Acute Hemispheric Stroke

TL;DR: CTA can provide important information for the initiation of therapy in patients with acute hemispheric ischemia and identification of patients with autolyzed thrombi, occlusion of the internal carotid artery bifurcation, and poor leptomeningeal collaterals is feasible with the use of CTA.
Journal ArticleDOI

Does Arterial Recanalization Improve Outcome in Carotid Territory Stroke

TL;DR: Even if delayed, arterial recanalization may improve clinical outcome in a subgroup of patients with middle cerebral artery occlusion.
Journal ArticleDOI

Stroke-Related Early Tracheostomy Versus Prolonged Orotracheal Intubation in Neurocritical Care Trial (SETPOINT) A Randomized Pilot Trial

TL;DR: Early tracheostomy in ventilated intensive care stroke patients is feasible, and safe, and presumably reduces sedation need, and whether the suggested benefits in mortality and outcome truly exist has to be determined by a larger multicenter trial.